Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phosphodiesterase inhibitors prepared and tested at GlaxoSmithKline

Jan. 28, 2005

Encouraging findings from phase I studies of GRC-3886

Jan. 28, 2005

Imatinib study identifies potential new pathway for asthma treatment

Jan. 27, 2005

Altana claims new combinations for respiratory disorders

Jan. 27, 2005

Lead antibodies identified under SOA-002 project collaboration

Jan. 26, 2005

Potent and selective CCR3 antagonist DPC-168 from BMS enters phase I

Jan. 26, 2005

Scientists at Pfizer claim beta2-adrenoceptor agonists for respiratory diseases

Jan. 24, 2005

Copernicus receives award to advance genetic therapy for cystic fibrosis

Jan. 24, 2005

Rigel and Pfizer sign collaborative and license agreement for respiratory diseases

Jan. 24, 2005

GSK and Galapagos enter asthma target discovery alliance

Jan. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...